The latest news about HotHouse Therapeutics
We were delighted to be interviewed by Max Barnhart of C&EN about our coming-out-of-stealth story.
Read morePioneering drug discovery platform company, HotHouse Therapeutics has successfully closed a £2.9m pre-seed funding round to transform modern medicine by developing sustainable, scalable pharmaceutical compounds through AI-optimised plant-based chemistry.
Read moreProfessor Anne Osbourn has been named on the Clarivate Highly Cited Researchers 2025 list, recognising researchers whose work is ranked among the top 1% by citations in their field over the past decade.
Read moreHotHouse Therapeutics joined the World Vaccine Congress Europe 2025 in Amsterdam, bringing our mission front and centre into the heart of the vaccine community.
Read moreWe’re proud to be nominated in the ‘Company’ category of the #21toWatch Awards 2026, which celebrate the innovators and businesses shaping the future of Cambridge and the East of England.
Read more